Clinical Trials Directory

Trials / Sponsors / Mast Therapeutics, Inc.

Mast Therapeutics, Inc.

Industry · 14 registered clinical trials.

StatusTrialPhaseStarted
CompletedStudy of the Effect of Renal Impairment on the Pharmacokinetics of Vepoloxamer
Pharmacokinetics of Vepoloxamer, Healthy Volunteers, Renal Impaired
Phase 12016-01-01
TerminatedEvaluation of Vepoloxamer in Chronic Heart Failure
Chronic Heart Failure
Phase 22015-10-01
CompletedEvaluation of Repeat Administration of Purified Poloxamer 188
Sickle Cell Disease
Phase 32015-06-01
TerminatedEvaluation of MST-188 in Acute Lower Limb Ischemia
Acute Limb Ischemia
Phase 22014-06-01
CompletedEvaluation of Purified Poloxamer 188 in Vaso-Occlusive Crisis of Sickle Cell Disease (EPIC)
Vaso-occlusive Crisis, Sickle Cell Disease
Phase 32013-05-01
CompletedANX-188 Thorough QT/QTc Study in Healthy Volunteers
Healthy
Phase 12013-02-01
CompletedA Clinical Trial of CoFactor Formulations and Leucovorin Administered Intravenously in Healthy, Adult Subjects
Healthy Adults
Phase 12008-04-01
CompletedA Bioequivalence Study of Docetaxel for Injectable Emulsion (ANX-514) in Patients With Advanced Cancer
Advanced Cancer
Phase 12008-04-01
CompletedA Bioequivalence Study of Vinorelbine Tartrate Injectable Emulsion in Patients With Advanced Cancer.
Breast Cancer, Non-small Cell Lung Cancer, Non-Hodgkins Lymphoma
Phase 12007-02-01
UnknownPhase III Randomized Study of 5-FU, CoFactor, and Avastin vs. 5-FU, LV and Avastin for First-Line Colorectal C
Metastatic Colorectal Cancer, Colon Cancer, Rectal Cancer
Phase 32006-05-01
Unknown5-Fluorouracil Combined With CoFactor (5-10 Methylenetetrahydrofolate) in Treating Advanced Breast Cancer Pati
Breast Cancer
Phase 22006-02-01
CompletedClinical Trial in Patients With Metastatic Colorectal Cancer
Colon Cancer, Rectal Cancer
Phase 22005-05-01
CompletedClinical Trial in Patients With Metastatic Colorectal Cancer
Colon Cancer, Rectal Cancer
Phase 22004-04-01
CompletedPhase III Randomized Study of Poloxamer 188 for Vaso-Occlusive Crisis of Sickle Cell Disease
Sickle Cell Anemia
Phase 31997-11-01